MEDICINES EVALUATION AND MONITORING GROUP - CENTRAL NERVOUS-SYSTEM EFFECTS OF PENTAZOCINE

被引：41

作者：

WOOD, AJJ

MOIR, DC

CAMPBELL, C

DAVIDSON, JF

GALLON, SC

HENNEY, E

MCALLION, S

机构：

[1] DUNDEE UNIV,DEPT PHARMACOL & THERAPEUTICS,DUNDEE DD1 4HN,SCOTLAND

[2] ABERDEEN UNIV,DEPT SOCIAL MED,ABERDEEN AB9 1AS,SCOTLAND

[3] MARYFIELD HOSP,DUNDEE,SCOTLAND

来源：

BRITISH MEDICAL JOURNAL | 1974年 / 1卷 / 5903期

关键词：

D O I：

10.1136/bmj.1.5903.305

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

引用

页码：305 / 307

页数：3

共 8 条

[1] METHOD OF MONITORING DRUGS FOR ADVERSE REACTIONS .1. ALPHA-METHYLDOPA AND HAEMOLYTIC ANAEMIA [J].

COULL, DC ;

CROOKS, J ;

DAVIDSON, JF ;

GALLON, SC ;

WEIR, RD .

EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY, 1970, 3 (01) :46-&

[2]

CROOKS J, 1965, LANCET, V1, P373

[3] HALLUCINATORY EFFECT OF PENTAZOCINE (TALWIN) [J].

DENOSAQUO, N .

JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1969, 210 (03) :502-+

[4]

EDISON GR, 1969, NEW ENGL J MED, V281, P447

[5]

HART RH, 1969, LANCET, V2, P690

[6]

MUNGAVIN JM, 1969, LANCET, V2, P56

[7] TOLERANCE AND DEPENDENCE ON PENTAZOCINE [J].

SANDOVAL, RG ;

WANG, RIH .

NEW ENGLAND JOURNAL OF MEDICINE, 1969, 280 (25) :1391-&

[8]

SCOLAR JC, 1969, LANCET, V1, P32

← 1 →